How High Can These Stocks Go? Great Basin Scientific Inc (GBSN) and Northwest Biotherapeutics Inc (NWBO)

Posted by Saimoon April 6, 2015 0 Comment 768 views


New York, NY – GDP INSIDER  –  04/06/2015.

This article discusses two companies: Great Basin Scientific Inc (NASDAQ:GBSN) and Northwest Biotherapeutics Inc (NASDAQ:NWBO)

Great Basin Scientific Inc (NASDAQ:GBSN) fell back slightly on Thursday with the stock declining 5.23% or $0.23 to close at $4.17 with more than 4.710 million shares changing hands, compared to its relatively low three month average trading volume of 0.469 million. The developer and manufacturer of test kits and analyzers for pathogens started to surge last week after it announced that the United States Patent and Trademark Office (USPTO) had approved the patent application for its sample to result molecular diagnostic technology. This increases the number of patents that Great Basin Scientific Inc can market to three and opens the way for it to develop a system that could potentially reduce the amount of systems that a hospital lab needs when processing tests. Even with Thursday profit taking, the stock has still gained 113.85% in the last week and is a definite hold and still a potential buy for now.

Can Great Basin Scientific Inc Keep Climbing? Take A Look At The Technical Indicators In Our Free GBSN Analysis.

Northwest Biotherapeutics Inc (NASDAQ:NWBO) started climbing again on Thursday with the stock gaining 6.30% or $0.46 to close at $7.76 on very active trading of 1.338 million shares, compared to its three month average trading volume of 0.581 million. The innovative cancer therapy development company saw the gains after it announced it had received $40 million in new financing from Woodward Investment Management LLP, through the purchase of common stocks at $7.40 per share to complete between April 8 and April 30. The stock has been trending upwards for the last six months and is far outperforming the S&P 500, with the stock up 45.04% YTD compared to the S&P 500 index which has only gained 0.39% over the same period. With Northwest Biotherapeutics Inc now converging towards a bullish MACD crossover and RSI in the middle at 57.27, it has the potential to make further gains, making it a hold and potential buy.

Is Northwest Biotherapeutics A Good Medium Term Investment? Click Here For Free NWBO Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment